Advanced search
Publication Cover
Archives of Environmental Health: An International Journal Volume 58, 2003 - Issue 8
Journal homepage
76
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Lipoic Acid as a Potential First Agent for Protection from Mycotoxins and Treatment of Mycotoxicosis

Sherry A. Rogers Northeast Center for Environmental Medicine Sarasota, Florida
Pages 528-532 | Published online: 07 Aug 2010

  • Vesconi S, Langer M. Therapy of cytotoxic mushroom intoxication. Crit Care Med 1985; 13:402-06.
  • Santilli J Jr, Rockwell WJ, Collins RP. Individual patterns of immediate skin reactivity to mold extracts. Ann Allergy 1990; 65:454-58.
  • Hayes JR, Campbell TC. Food additives and contaminants. In: Klaasen CD, Amdur MO, Doull J (Eds). Casarett and Doull's Toxicology. The Basic Science of Poisons, 3rd ed. New York: Macmillan, 1986; pp 794-800.
  • Watson DH. Toxic fungal metabolites in food. Crit Rev Food Sci Nutr 1985; 22(3):177-98.
  • Fukushima C, Matsuse H, Tomari S, et al. Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. Ann Allergy Asthma Immunol 2003; 90:646-51.
  • Beasley VR. Trichothecene Mycotoxicosis: Pathophysiologic Effects, Vol 2. Boca Raton, FL: CRC Press, 1989.
  • Yarom R, Sherman Y, Yagen B, et al. T-2 toxin effect on bacterial infection and leukocyte functions. Toxicol Appl Pharmacol 1985; 75:60-65.
  • Wang JS, Groopman JD. DNA damage by mycotoxins. Mutat Res 1999; 424:167-81.
  • Aguilar F, Hussain SP, Cerutti P. Aflatoxin B1 induces the transversion of G−> in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci USA 1993; 90:8586-90.
  • Newberne PM. Chemical carcinogenesis: mycotoxins and other chemicals to which humans are exposed. Semin Liver Dis 1984; 4(2):122-35.
  • Nyandieka HS, Wakhisi J, Kilonzo MM. Association of reduction of AFB1-induced liver tumors by antioxidants with increased activity of microsomal enzymes. Indian J Med Res 1990; 92:332-36.
  • Novi A. Regression of aflatoxin B1-induced carcinomas by reduced glutathione. Science 1981; 212(4494):541-42.
  • Rogers SA. Indoor fungi as part of the cause of recalcitrant symptoms of the tight building syndrome. Environment Int 1991; 17(4):271-76.
  • Savilahti R, Uitti J, Roto P, et al. Increased prevalence of atopy among children exposed to mold in a school building. Allergy 2001; 56:175-79.
  • Dziadzio L, Bush RK. Assessment and control of fungal allergens. Curr Allergy Asthma Rep 2001; 1:455-60.
  • Rogers SA. A 13-month work, leisure, sleep environmental fungal survey. Ann Allergy 1984; 52:338-41.
  • Rogers SA. Diagnosing the tight building syndrome. Environ Health Perspect 1987; 76:195-98.
  • Kojima R, Toyama Y, Ohnishi ST. Protective effects of an aged garlic extract on doxorubicin-induced cardiotoxicity in the mouse. Nutr Cancer 1994; 22:163-73.
  • Geetha A, Sankar R, Marar T, et al. Alpha tocopherol reduces doxorubicin-induced toxicity in rats: histological and biochemical evidences. Indian J Physiol Pharmacol 1990; 34:94-100.
  • Chen J, Goetchius MP, Campbell TC, et al. Effects of dietary selenium and vitamin E on hepatic mixed-function oxidase activities and in vivo covalent binding of aflatoxin B1 in rats.J Nutr 1982; 112(2):324-31.
  • Boyd JN, Babish JG, Stoewsand GS. Modification by beet and cabbage diets of aflatoxin B1-induced rat plasma α-foetoprotein elevation, hepatic tumorigenesis, and mutagenicity of urine. Food Chem Toxicol 1982; 20:47-52.
  • Fong AT, Swanson HI, Dashwood RH, et al. Mechanisms of anti-carcinogenesis by indole-3-carbinol. Studies of the enzyme induction, electrophile-scavenging, and inhibition of aflatoxin B1 activation. Biochem Pharmacol 1990; 390(1):19-26.
  • Hansen DE, Black G, Levine M. Ascorbic acid: biological functions and relation to cancer. J Natl Cancer Inst 1991; 83:547-50.
  • Podda M, Tritschler HJ, Ulrich H, et al. Alpha-lipoic acid supplementation prevents symptoms of vitamin E deficiency. Biochem Biophys Res Commun 1994; 204: 98-104.
  • Han D, Tritscherl HJ, Packer L. Alpha-lipoic acid increases intracellular glutathione in human T-lymphocyte Jurkat cell line. Biochem Biophys Res Commun 1995; 207: 258-64.
  • Ramkrishnan N, Wolff WW. Radioprotection of haemotopoietic tissues in mice by lipoic acid. Radiat Res 1992; 130:360-65.
  • Altenkirch H, Stoltenberg-Didinger H, Wagner H, et al. Effect of lipoic acid in carbon-induced neuropathy. Neurotoxicol Teratol 1990; 12:619-22.
  • Sandhya P, Varalakshmi P. Effect of lipoic acid administration lipid peroxidation in rats. J Appl Toxicol 1997; 17: 405-08.
  • Conlon BJ, Aran JM, Erre JP, et al. Attenuation of amino glycosides-induced cochlear damage with the metabolic antioxidant alpha-lipoic acid. Hear Res 1999; 128(1-2): 40-44.
  • Devasagayam TPA, Subramanian M, Pradhan DS, et al. Prevention of singlet oxygen-induced DNA damage by lipoate. Chem Biol Interact 1993; 86:79-92.
  • Mizuno M, Packer L. Effects of alpha lipoic acid and dihydrolipoic acid on expression of proto-oncogene c-fos. Biochem Biophys Res Commun 1994; 200(2):1136-12.
  • Sumathi R, Devi VK, Varalakshmi P. DL α-lipoic acid protection against cadmium-induced tissue lipid peroxidation. Med Sci Res 1994; 22:23-25.
  • Kropachova K, Mishurova E. Flavobion and thiocic acid lessen radiation-induced latent injury of the liver. Biull Eksp Biol Med 1992; 113(5):547-49.
  • Korkina LG, Afanasef IB, Diplock AT. Antioxidant therapy in children affected by a radiation from the Chernobyl nuclear accident. Biochem Soc Trans 1993; 21:S314.
  • Bast A, Haenen GRMM. Interplay between lipoic acid and glutathione in the protection against microsomal lipid peroxidation. Biochim Biophys Acta 1988; 963: 558-61.
  • Kagan VE, Shvedova A, Servinova E, et al. Dihydrolipoic acid: a universal antioxidant both in the membrane and in the aqueous phase. Biochem Pharmacol 1992; 44: 1637-49.
  • Scholich H, Murphy ME, Eies H. Antioxidant activity of dihydrolipoate against microsomal lipid peroxidation and its dependence on α-tocopherol. Biochim Biophys Acta 1989; 1001:256-61.
  • Berkson BM. Alpha-lipoic acid (thioctic acid): my experience with this outstanding therapeutic agent. J Orthomol Med 1998; 13(1):44-48.
  • Rogers SA. Detoxify or Die. Syracuse, NY: Prestige, 2002. Available from www.prestigepublishing.com
  • Gal EM. Reversal of selective toxicity of (-)-α-lipoic acid by thiamine in thiamine-deficient rats. Nature 1965; 207:535.
  • Gregus Z, Fekete T, Klaassen CD, et al. Lipoic acid impairs glycine conjugation of benzoic acid and renal excretion of benzoylglycine. Drug Metab Dispos 1996; 245: 682-88.
  • Trickler D, Shklar G, Schwartz J. Inhibition of oral carcinogenesis by glutathione. Nutr Cancer 1993; 20(2):139-44.
  • Vogel G, Tuchweber B, Trost W, et al. Protection by silibinin against Amanita phylloides intoxication in beagles. Toxicol Appl Pharmacol 1984; 73:355-62.
  • Suzuki Y, Tsuchiiya M, Packer L. Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Rad Res Commun 1991; 15:255-63.
  • Scott B, Aruoma O. Lipoic and dihydrolipoic acid as antioxidants. Free Radic Res 1994; 20:119-33.
  • Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med 1995; 19: 227-50.
  • Dikalov S, Khramtsov C, Zimmer G. Reaction of lipoate and its derivatives with reactive oxygen species. In: Fuchs J, Packer L, Zimmer G (Eds). Lipoic Acid in Health and Disease. New York: Marcel Dekker, 1997; pp 47-66.
  • Hagen TM, Ingersoll RT, Lykkesfeldt J, et al. (R)- α-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. FASEB J 1999; 13:411-18.
  • Ou P, Tritschler HJ, Wolff SP. Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? Biochem Pharmacol 1995; 50:123-26.
  • Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol 1997; 29:315-31.
  • Muller L, Menzel H. Studies on the efficacy of lipoate and dihydrolipoate in the alteration of cadmium toxicity in isolated hepatocytes. Biochem Biophys Acta 1990; 1052:386-91.
  • Bauer A, Harrer T, Peukert M, et al. Alpha-lipoic acid is an effective inhibitor of human immunodeficiency virus replication. Wien Klin Wochenschr 1991; 69:722-24.
  • Grieb G. Alpha lipoic acid inhibits HIV replication. Med Monatsschr Pharma 1992; 15(8):243-44.
  • Zimmer G, Manika L, Kruger E. Dihydrolipoic acid activates oligomycin-sensitive thiol groups and increases ATP synthesis in mitochondria. Arch Biochem Biophys 1991; 288:609-13.
  • Packer L. Antioxidant properties of lipoic acid and its therapeutic effect in prevention of diabetes complications and cataracts. Ann NY Acad Sci 1994; 734:257-64.
  • Gut J, Christen U, Frey N, et al. Molecular mimicry in halothane hepatitis: biochemical and structural characterization of lipoylated autoantigens. Toxicology 1995; 97 (1-3):199-224.
  • Arivazhagen P, Juliet P, Panneerselvam C. Effect of DL-alpha lipoic acid on the status of lipid peroxidation and antioxidants in aged rats. Pharmacol Res 2000; 41:299-303.
  • Halliwell B, Gutteriedge JMC. Free Radicals in Biology and Medicine, 3rd ed. New York: Oxford University Press, 1999; p 194.
  • Peinado J, Sies H, Akerboom TP. Hepatic lipoate uptake. Arch Biochem Biophys 1989; 273:389-95.
  • Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med 1997; 22:359-78.
  • Nagamatsu M, Nickander KK, Low P, et al. α-lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 1995, 18(8):1160-67.
  • Nohl H, Gille L. Evaluation of the antioxidant capacity of ubiquinol and dihydrolipoic acid. J Biosci 1998; 53: 250-53.
  • Loffelhardt S, Bonaventura C, Locher M, et al. Interaction of α-lipoic acid in enantiomers and homologues with the enzyme components of the mammalian pyruvate dehydrogenase complex. Biochem Pharmacol 1995; 15(5):637-46.
  • Han D, Handleman G, Marcxocci L, et al. Lipoic acid increases the de novo synthesis of cellular glutathione by improving cystine utilization. Biofactors 1997; 6:321-38.
  • Wells WW, Xu DP, Yang Y, et al. Mammalian thiol transferase (glutaredoxin) and protein disulfide isomerase have dehydroascorbate reductase activity. J Biol Chem 1990; 265:15361-64.
  • O'Neill CA, Hallowell B. Aldehyde-induced protein modifications in human plasma. Protection by glutathione and dihydrolipoic acid. J Lab Clin Med 1994; 124(3):359-70.
  • Thompson CM. Addition of thioctic acid to a plan for management of hepatic insufficiency. Am J Med 1956; 21:131-32.
  • Kemplay S, Martin P, Wilson S. The effects of thioctic acid on motor nerve terminals in acrylamide-poisoned rats. Neuropathol Appl Neurobiol 1988; 14:275-88.
  • Piering WF, Bratanow N. Role of the clinical laboratory in guiding treatment of Amanita virosa mushroom poisoning: report of two cases. Clin Chem 1990; 36(3):571-74.
  • Nagy I, Pogatsa-Murray G, Zalanyi S Jr, et al. Amanita poisoning during the second trimester of pregnancy. A case report and a review of the literature. Clin Investig 1994; 72:794-98.
  • Sabeel Al, Kurkus J, Lindholm T. Intensive hemodialysis and hemoperfusion treatment of Amanita mushroom poisoning. Mycopathologia 1995; 131:107-14.
  • Bartter FC, Berkson B, Gallelli J. Thioctic acid in the treatment of poisoning with alpha-amanitin. In: Faulstich H, Kommerell B, Wieland T (Eds). Amanita Toxins and Poisoning. Baden Baden, Germany: Verlag Gerhard Witzstrock, 1980; pp 197-202.
  • Steyn DG. The treatment of cases of Amanita phylloides and Amanita capensis poisoning. S Afr Med J 1966; 40: 405-06.
  • Berkson BM. A conservative triple antioxidant approach to the treatment of hepatitis C. Combination of alpha lipoic acid (thioctic acid), silymarin, and selenium: three case histories. Med Klin 1994; 94:S84-89.
  • Wieland TH, Faulstich H. Amatoxin, phallotoxins, phallolysin and antaminide: the biologically active components of poisonous Amanita mushrooms, Crit Rev Biochem 1978; 5:185-260.
  • Culliton BJ. The destroying angel: a story of a search for an antidote. Science 1974; 185:600-01.
  • Berkson BM. Thioctic acid in treatment of hepatotoxic mushroom poisoning. N Engl J Med 1979; 300:371.
  • Berkson B. Treatment of four patients with thioctic acid. In: Faulstich H, Kommerell B, Wieland T (Eds). Amanita Toxins and Poisonings. Baden Baden, Germany: Verlag Gerhard Witzstrock, 1980; pp 203-07.
  • Teutsch C, Brennan RW. Amanita mushroom poisoning with recovery from coma, a case report. Ann Neurol 1978; 3:171-79.
  • Tadi PP, Teel RW, Lau BHS, et al. Organosulfur compounds of garlic modulate mutagenesis, metabolism and DNA binding of aflatoxin B1. Nutr Cancer 1991; 15:87-95.
  • Lei DN, Wang LQ, Ruebner BH, et al. Effect of selenium on aflatoxin hepatocarcinogenesis in the rat. Biomed Environ Sci 1990; 3(1):65-80.
  • Ueno Y. The toxicology of mycotoxins. Crit Rev Toxicol 1983; 14(2):99-132.
  • Uragashi K. Mycotoxic origin of cardiac beriberi. J Stored Prod Res 1969; 5:227.
  • Kroft WA, Jarvis BB, Yatawara CS. Airborne outbreak of trichothecene toxicosis. Atmos Environ 1986; 20(3): 549-52.
  • Etzel RE, Montana E, Sorenson W, et al. Acute hemorrhage in infants associated with exposure to Stachybotrys atra and other fungi. Arch Pediatr Adolesc Med 1998; 152:757-62.
  • Leszczyszyn J. Growth of transplantable aflatoxin B1-induced mammary cancer in Wistar rats during treatment with BCG vaccine. Patol Pol 1986; 37(3):222-36.
  • Nassar AY, Galal AF, Mohamed MA, et al. The effect of aflatoxin B1 on the utilization of serum calcium. Mycopathologia 1985; 91(2):127-31.
  • Lindsay DG. Zeranol—a "nature-identical" oestrogen? Food Chem Toxicol 1985; 23(8):767-74.
  • Parish RC, Doering PL. Treatment of Amanita mushroom poisoning: a review. Vet Hum Toxicol 1986; 28(4):318-22.
  • Becker CE. Diagnosis and treatment of Amanita phylloides-type mushroom poisoning: use of thioctic acid. West J Med 1976; 125:100-09.
  • Roldan EJA, Lloret AP. Thioctic acid in Amanita poisoning. Crit Care Med 1986; 14:753.
  • Zulik R. Death cap poisoning. Lancet 1972; 11:288.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.